Holen Sie sich die Stockscreener-App
2.1545
1.18%
0.0395
Schlusskurs vom Vortag:
$2.115
Offen:
$2.19
24-Stunden-Volumen:
46,322
Relative Volume:
0.09
Marktkapitalisierung:
$272.12M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-70.78M
KGV:
-3.8473
EPS:
-0.56
Netto-Cashflow:
$-61.27M
1W Leistung:
+18.89%
1M Leistung:
+50.70%
6M Leistung:
+172.75%
1J Leistung:
-10.08%
1-Tages-Spanne:
$2.0665
$2.20
1-Wochen-Bereich:
$1.80
$2.54
52-Wochen-Spanne:
$0.62
$2.54
Nautilus Biotechnology Inc Stock (NAUT) Company Profile
Firmenname
Nautilus Biotechnology Inc
Sektor
Branche
Telefon
206-333-2001
Adresse
2701 EASTLAKE AVE EAST, SEATTLE
Vergleichen Sie NAUT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NAUT
Nautilus Biotechnology Inc
|
2.1545 | 267.14M | 0 | -70.78M | -61.27M | -0.56 |
|
VRTX
Vertex Pharmaceuticals Inc
|
432.56 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
743.96 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
444.05 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
922.80 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
197.94 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Nautilus Biotechnology Inc Stock (NAUT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-05 | Herabstufung | Goldman | Neutral → Sell |
| 2024-06-27 | Eingeleitet | Guggenheim | Buy |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2022-01-06 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-11-02 | Eingeleitet | Cowen | Outperform |
| 2021-08-04 | Eingeleitet | Goldman | Neutral |
| 2021-07-13 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Nautilus Biotechnology Inc Aktie (NAUT) Neueste Nachrichten
There is no way Nautilus Biotechnology Inc (NAUT) can keep these numbers up - Setenews
Advanced analytics toolkit walkthrough for Nautilus Biotechnology Inc.2025 Trading Recap & Precise Trade Entry Recommendations - newser.com
What dividend safety score for Nautilus Biotechnology Inc. stockMarket Growth Report & Low Volatility Stock Recommendations - newser.com
Long term hold vs stop loss in Nautilus Biotechnology Inc.Market Risk Summary & Daily Profit Focused Stock Screening - newser.com
Will Nautilus Biotechnology Inc. stock maintain momentum in 2025Recession Risk & Low Drawdown Investment Ideas - newser.com
Has Nautilus Biotechnology Inc. found a price floorMarket Growth Summary & Free High Accuracy Swing Entry Alerts - newser.com
What candlestick patterns are forming on Nautilus Biotechnology Inc.Weekly Trend Recap & Reliable Price Breakout Signals - newser.com
Will Nautilus Biotechnology Inc. stock outperform value stocksMarket Trend Summary & Reliable Volume Spike Trade Alerts - newser.com
Why Nautilus Biotechnology Inc. stock is recommended by analystsMarket Activity Summary & Risk Controlled Swing Trade Alerts - newser.com
Wall Street Zen Upgrades Nautilus Biotechnology (NASDAQ:NAUT) to Hold - Defense World
How to recover losses in Nautilus Biotechnology Inc. stockBull Run & Technical Entry and Exit Alerts - newser.com
Why Nautilus Biotechnology Inc. stock is considered a top pickMarket Sentiment Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Is Nautilus Biotechnology Inc. stock oversold or undervaluedEarnings Overview Summary & Free High Return Stock Watch Alerts - newser.com
How Nautilus Biotechnology Inc. stock performs in rate cut cyclesPortfolio Update Report & Community Trade Idea Sharing Platform - newser.com
How geopolitical tensions affect Nautilus Biotechnology Inc. stock2025 Breakouts & Breakdowns & Real-Time Volume Triggers - newser.com
Published on: 2025-11-13 14:26:20 - newser.com
Strategies to average down on Nautilus Biotechnology Inc.Trade Entry Report & Weekly Stock Breakout Alerts - newser.com
Can Nautilus Biotechnology Inc. stock weather global recessionBuy Signal & High Conviction Buy Zone Alerts - newser.com
Suzuki Kentaro buys Nautilus Biotechnology shares worth $5,960 By Investing.com - Investing.com Canada
[Form 4] Nautilus Biotechnology, Inc. Insider Trading Activity - Stock Titan
Officer Suzuki Buys 4,000 ($6K) Of Nautilus Biotechnology Inc [NAUT] - TradingView
Wall Street Zen Downgrades Nautilus Biotechnology (NASDAQ:NAUT) to Sell - Defense World
Nautilus Biotechnology redefines proteomics at HUPO2025 - Traders Union
Is this a good reentry point in Nautilus Biotechnology Inc.Share Buyback & Precise Trade Entry Recommendations - newser.com
Nautilus announces installation, testing of its external field evaluation unit - MSN
Finanzdaten der Nautilus Biotechnology Inc-Aktie (NAUT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Nautilus Biotechnology Inc-Aktie (NAUT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Patel Sujal M | CEO, President, and Secretary |
Sep 05 '25 |
Buy |
0.67 |
116,500 |
78,544 |
10,258,221 |
| Patel Sujal M | CEO, President, and Secretary |
Sep 08 '25 |
Buy |
0.68 |
83,500 |
57,031 |
10,341,721 |
| Murphy Matthew B. | General Counsel |
Sep 04 '25 |
Buy |
0.64 |
20,000 |
12,858 |
74,140 |
| Mowry Anna | CFO and Treasurer |
May 29 '25 |
Buy |
0.77 |
15,000 |
11,488 |
83,000 |
| Mallick Parag | Chief Scientist |
May 08 '25 |
Buy |
0.73 |
12,000 |
8,788 |
20,491,892 |
| Mallick Parag | Chief Scientist |
May 12 '25 |
Buy |
0.73 |
1,500 |
1,098 |
20,493,392 |
| Patel Sujal M | CEO, President, and Secretary |
Mar 19 '25 |
Buy |
0.99 |
53,300 |
53,028 |
10,117,788 |
| Patel Sujal M | CEO, President, and Secretary |
Mar 20 '25 |
Buy |
1.00 |
23,933 |
23,890 |
10,141,721 |
0.09%
1.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):